약학회지

ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)
Table. 1. Baseline characteristics of subjects
Control group N=11347 (%) Parkinson’s disease group N=11347 (%) p-value
Sex 1.000
Male 6496 (57.25) 6496 (57.25)
Female 4851 (42.75) 4851 (42.75)
Age, years (mean±SD) 72.3±6.9 72.3±6.9 1.000
Charlson Comorbidity Index 5.93±3.4 6.96±3.7 <0.001
0-2 2787 (24.56) 1929 (17.00)
3-5 4339 (38.24) 3678 (32.41)
6≤ 4221 (37.20) 5740 (50.59)
Comorbidities
Myocardial infarction 387 (3.41) 559 (4.93) <0.001
Congestive heart failure 1719 (15.15) 2429 (21.41) <0.001
Peripheral vascular disease 3747 (33.02) 4758 (41.93) <0.001
Cerebrovascular disease 2690 (23.71) 4590 (40.45) <0.001
Dementia 1503 (13.25) 3268 (28.20) <0.001
Chronic pulmonary disease 6858 (60.44) 7437 (65.54) <0.001
Rheumatic disease 1132 (9.98) 1531 (13.49) <0.001
Peptic ulcer disease 6363 (56.08) 7013 (61.08) <0.001
Mild liver disease 5766 (50.82) 6469 (57.01) <0.001
Diabetic without chronic complications 5430 (47.85) 6420 (56.58) <0.001
Mild renal disease 1075 (9.47) 1446 (12.74) <0.001
Diabetic with chronic complications 2005 (17.67) 2777 (24.47) <0.001
Hemiplegia or paraplegia 298 (2.63) 639 (5.63) <0.001
Severe liver disease 135 (1.19) 182 (1.60) 0.0079
Severe renal disease 344 (3.03) 496 (4.37) <0.001
Yakhak Hoeji 2024;68:371-7 https://doi.org/10.17480/psk.2024.68.5.371
© 2024 Yakhak Hoeji